부산대학교 도서관

Clarizia, Fabio; Colace, Francesco; De Santo, Massimo; Lombardi, Marco; Pascale, Francesco; Pietrosanto, Antonio

Proceedings of the 6th International Conference on Information and Education Technology. :111-118

Azienda Ospedaliera Universitaria Pisana, Pisa; Gaetano Pini CTO, Milano; IRCCS Humanitas Research Hospital, Milano; Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale; Ospedale 'Morgagni - Pierantoni' di Forlì; AOU Città della Salute e della Scienza Torino; Azienda Consorziale Ospedaliero-Universitaria Policlinico di Bari

Clear Cell Chondrosarcoma in Italy: Insights Into Radiological, Clinical and pathologicaL Features, With Emphasis on Prognosis (CIRCLE)

von Niman, Bruno; Böcker, Martin; Schneider-Hufschmidt, Matthias; Flygt, Margareta; Parodi, Pascale; Ketola, Pekka; Williams, David; Tate, Michael

Proceedings of the 7th international conference on Human computer interaction with mobile devices & services. :357-358

European Commission; Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale; Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialità San Giuseppe Moscati (Avellino)

Radioimmunotherapy in Solid Tumors (Aim 2- Stereotactic Neoadjuvant Radiotherapy for Glioblastoma)
Thust SC, Heiland S, Falini A, Jager HR, Waldman AD, Sundgren PC, Godi C, Katsaros VK, Ramos A, Bargallo N, Vernooij MW, Yousry T, Bendszus M, Smits M. Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice. Eur Radiol. 2018 Aug;28(8):3306-3317. doi: 10.1007/s00330-018-5314-5. Epub 2018 Mar 13.
Castellano A, Falini A. Progress in neuro-imaging of brain tumors. Curr Opin Oncol. 2016 Nov;28(6):484-493. doi: 10.1097/CCO.0000000000000328.
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010 Apr 10;28(11):1963-72. doi: 10.1200/JCO.2009.26.3541. Epub 2010 Mar 15.
Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S; Glioma Outcomes Investigators. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003 Sep;99(3):467-73. doi: 10.3171/jns.2003.99.3.0467.
Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, Glantz M. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. JAMA Oncol. 2016 Nov 1;2(11):1460-1469. doi: 10.1001/jamaoncol.2016.1373.
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001 Aug;95(2):190-8. doi: 10.3171/jns.2001.95.2.0190.
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163.
Desai K, Hubben A, Ahluwalia M. The Role of Checkpoint Inhibitors in Glioblastoma. Target Oncol. 2019 Aug;14(4):375-394. doi: 10.1007/s11523-019-00655-3.
Gzell C, Back M, Wheeler H, Bailey D, Foote M. Radiotherapy in Glioblastoma: the Past, the Present and the Future. Clin Oncol (R Coll Radiol). 2017 Jan;29(1):15-25. doi: 10.1016/j.clon.2016.09.015. Epub 2016 Oct 13.
Valduvieco I, Verger E, Bruna J, Caral L, Pujol T, Ribalta T, Boget T, Oleaga L, Pineda E, Graus F. Impact of radiotherapy delay on survival in glioblastoma. Clin Transl Oncol. 2013 Apr;15(4):278-82. doi: 10.1007/s12094-012-0916-x. Epub 2012 Jul 24.
Burko P, D'Amico G, Miltykh I, Scalia F, Conway de Macario E, Macario AJL, Giglia G, Cappello F, Caruso Bavisotto C. Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles? Int J Mol Sci. 2023 Mar 2;24(5):4883. doi: 10.3390/ijms24054883.
Tang Z, Dokic I, Knoll M, Ciamarone F, Schwager C, Klein C, Cebulla G, Hoffmann DC, Schlegel J, Seidel P, Rutenberg C, Brons S, Herold-Mende C, Wick W, Debus J, Lemke D, Abdollahi A. Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):499-513. doi: 10.1016/j.ijrobp.2021.09.017. Epub 2021 Sep 14.
Pant A, Lim M. CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement. Cancers (Basel). 2023 Feb 16;15(4):1249. doi: 10.3390/cancers15041249.
Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, Ruda R, Short S, Smits M, Taphoorn MJB, von Deimling A, Westphal M, Soffietti R, Reifenberger G, Wick W. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8.
Trone JC, Vallard A, Sotton S, Ben Mrad M, Jmour O, Magne N, Pommier B, Laporte S, Ollier E. Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis. Radiat Oncol. 2020 Jun 8;15(1):145. doi: 10.1186/s13014-020-01584-6.
Lu VM, Kerezoudis P, Brown DA, Burns TC, Quinones-Hinojosa A, Chaichana KL. Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis. J Neurooncol. 2019 Jun;143(2):177-185. doi: 10.1007/s11060-019-03155-6. Epub 2019 Mar 27.
Liao G, Zhao Z, Yang H, Li X. Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis. Front Oncol. 2019 Oct 14;9:1017. doi: 10.3389/fonc.2019.01017. eCollection 2019.
Kotecha R, Mehta MP. Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes. Neuro Oncol. 2020 Aug 17;22(8):1062-1064. doi: 10.1093/neuonc/noaa133. No abstract available.
Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Harsh GR, Adler JR, Harraher C, Li G, Hayden Gephart M, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG. A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes. Neuro Oncol. 2020 Aug 17;22(8):1182-1189. doi: 10.1093/neuonc/noaa019.
Mendoza MG, Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Adler JR, Harraher C, Li G, Gephart MH, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG. Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide. Pract Radiat Oncol. 2023 May-Jun;13(3):e239-e245. doi: 10.1016/j.prro.2023.01.008. Epub 2023 Feb 2.
Kumar N, Kumar R, Sharma SC, Mukherjee A, Khandelwal N, Tripathi M, Miriyala R, Oinam AS, Madan R, Yadav BS, Khosla D, Kapoor R. Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols. Neurooncol Pract. 2020 Jan;7(1):86-93. doi: 10.1093/nop/npz024. Epub 2019 Jul 18.
Gao X, McDonald JT, Hlatky L, Enderling H. Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res. 2013 Mar 1;73(5):1481-90. doi: 10.1158/0008-5472.CAN-12-3429. Epub 2012 Dec 26.
Grossman SA, Ye X, Lesser G, Sloan A, Carraway H, Desideri S, Piantadosi S; NABTT CNS Consortium. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res. 2011 Aug 15;17(16):5473-80. doi: 10.1158/1078-0432.CCR-11-0774. Epub 2011 Jul 7.
Rudra S, Hui C, Rao YJ, Samson P, Lin AJ, Chang X, Tsien C, Fergus S, Mullen D, Yang D, Thotala D, Hallahan D, Campian JL, Huang J. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):217-225. doi: 10.1016/j.ijrobp.2018.01.069. Epub 2018 Feb 1.
Yovino S, Kleinberg L, Grossman SA, Narayanan M, Ford E. The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest. 2013 Feb;31(2):140-4. doi: 10.3109/07357907.2012.762780.
Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol. 2014 Apr;37(2):177-81. doi: 10.1097/COC.0b013e318271ae03.
Minniti G, Tini P, Giraffa M, Capone L, Raza G, Russo I, Cinelli E, Gentile P, Bozzao A, Paolini S, Esposito V. Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis. Radiother Oncol. 2023 Apr;181:109435. doi: 10.1016/j.radonc.2022.11.024. Epub 2022 Dec 16.
Singh R, Lehrer EJ, Wang M, Perlow HK, Zaorsky NG, Trifiletti DM, Bovi J, Navarria P, Scoccianti S, Gondi V, Brown PD, Palmer JD. Dose Escalated Radiation Therapy for Glioblastoma Multiforme: An International Systematic Review and Meta-Analysis of 22 Prospective Trials. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):371-384. doi: 10.1016/j.ijrobp.2021.05.001. Epub 2021 May 12.
Ling AL, Solomon IH, Landivar AM, Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS, Grant J, Zhang A, Bernstock JD, Torio E, Ito H, Liu J, Shono N, Nowicki MO, Triggs D, Halloran P, Piranlioglu R, Soni H, Stopa B, Bi WL, Peruzzi P, Chen E, Malinowski SW, Prabhu MC, Zeng Y, Carlisle A, Rodig SJ, Wen PY, Lee EQ, Nayak L, Chukwueke U, Gonzalez Castro LN, Dumont SD, Batchelor T, Kittelberger K, Tikhonova E, Miheecheva N, Tabakov D, Shin N, Gorbacheva A, Shumskiy A, Frenkel F, Aguilar-Cordova E, Aguilar LK, Krisky D, Wechuck J, Manzanera A, Matheny C, Tak PP, Barone F, Kovarsky D, Tirosh I, Suva ML, Wucherpfennig KW, Ligon K, Reardon DA, Chiocca EA. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature. 2023 Nov;623(7985):157-166. doi: 10.1038/s41586-023-06623-2. Epub 2023 Oct 18.
Jiang C, Mogilevsky C, Belal Z, Kurtz G, Alonso-Basanta M. Hypofractionation in Glioblastoma: An Overview of Palliative, Definitive, and Exploratory Uses. Cancers (Basel). 2023 Nov 29;15(23):5650. doi: 10.3390/cancers15235650.
Lhuillier C, Rudqvist NP, Elemento O, Formenti SC, Demaria S. Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. Genome Med. 2019 Jun 20;11(1):40. doi: 10.1186/s13073-019-0653-7.
Chajon E, Castelli J, Marsiglia H, De Crevoisier R. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership. Crit Rev Oncol Hematol. 2017 Mar;111:124-132. doi: 10.1016/j.critrevonc.2017.01.017. Epub 2017 Feb 4.

Andrew S Levey; Kai-Uwe Eckardt; Nijsje M Dorman; Stacy L Christiansen; Ewout J Hoorn; Julie R Ingelfinger; Lesley A Inker; Adeera Levin; Rajnish Mehrotra; Paul M Palevsky; Mark A Perazella; Allison Tong; Susan J Allison; Detlef Bockenhauer; Josephine P Briggs; Jonathan S Bromberg; Andrew Davenport; Harold I Feldman; Denis Fouque; Ron T Gansevoort; John S Gill; Eddie L Greene; Brenda R Hemmelgarn; Matthias Kretzler; Mark Lambie; Pascale H Lane; Joseph Laycock; Shari E Leventhal; Michael Mittelman; Patricia Morrissey; Marlies Ostermann; Lesley Rees; Pierre Ronco; Franz Schaefer; Jennifer St Clair Russell; Caroline Vinck; Stephen B Walsh; Daniel E Weiner; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; 王忍; 高春林; 夏正坤; 张沛

临床儿科杂志 / Journal of Clinical Pediatrics. 40(8):627-633

Malvasi M; Pascale E; Locuratolo N; Fattapposta F; Pauletti C; Finoia MG; Conti ME; Pacella E.

European Journal of Ophthalmology. 35:1746-1760

Mohamad Wehbe; Rudy N. Zalzal; Riyad El‐Khoury; Lama Charafeddine; Pascale E. Karam

Clinical Genetics. 108:463-467

Zak, J.; Boffin, H. M. J.; Sedaghati, E.; Bocchieri, A.; Changeat, Q.; Fukui, A.; Hatzes, A.; Hillwig, T.; Hornoch, K.; Itrich, D.; Ivanov, V. D.; Jones, D.; Kabath, P.; Kawai, Y.; Mugnai, L. V.; Murgas, F.; Narita, N.; Palle, E.; Pascale, E.; Pravec, P.; Redfield, S.; Roccetti, G.; Roth, M.; Srba, J.; Tian, Q.; Tsiaras, A.; Turrini, D.; Vignes, J. P.

Zak, J.; Bocchieri, A.; Sedaghati, E.; Boffin, H. M. J.; Prudil, Z.; Skarka, M.; Changeat, Q.; Pascale, E.; Itrich, D.; Ivanov, V. D.; Vitkova, M.; Kabath, P.; Roth, M.; Hatzes, A.

Presidio Ospedaliero Santo Spirito, Pescara; IRCCS Centro di Riferimento Oncologico di Basilicata, Potenza; Azienda Ospedaliera Pugliese Ciaccio; Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale; Azienda Ospedaliera dei Colli; Azienda Ospedaliero-Universitaria di Parma; IRCCS in Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia, Reggio Emilia; Istituto Nazionale dei Tumori Regina Elena, Roma; Ospedale Policlinico San Martino; A.O. Ospedale Papa Giovanni XXIII; Azienda Ospedaliero, Universitaria Ospedali Riuniti; Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento; San Luigi Gonzaga Hospital; Istituto Tumori Giovanni Paolo II, BARI; Azienda Ospedaliera per l'Emergenza Canizzaro; Azienda Ospedaliero-Universitaria Careggi; Istituto Oncologico Veneto IRCCS

Early Diagnosis of Lung Cancer of the Italian Pulmonary Screening Network (RISP): Comparative Analysis for the Use of Low Dose Computed Tomography and Promotion of Primary Prevention Interventions in Subjects at High Risk for Lung Cancer
Pastorino U, Ladisa V, Trussardo S, Sabia F, Rolli L, Valsecchi C, Ledda RE, Milanese G, Suatoni P, Boeri M, Sozzi G, Marchiano A, Munarini E, Boffi R, Gallus S, Apolone G. Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial. J Thorac Oncol. 2022 Nov;17(11):1276-1286. doi: 10.1016/j.jtho.2022.07.007. Epub 2022 Jul 28.
Milanese G, Sabia F, Ledda RE, Sestini S, Marchiano AV, Sverzellati N, Pastorino U. Volumetric Measurements in Lung Cancer Screening Reduces Unnecessary Low-Dose Computed Tomography Scans: Results from a Single-Center Prospective Trial on 4119 Subjects. Diagnostics (Basel). 2022 Jan 18;12(2):229. doi: 10.3390/diagnostics12020229.
Pastorino U, Boeri M, Sestini S, Sabia F, Milanese G, Silva M, Suatoni P, Verri C, Cantarutti A, Sverzellati N, Corrao G, Marchiano A, Sozzi G. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial. Ann Oncol. 2022 Apr;33(4):395-405. doi: 10.1016/j.annonc.2022.01.008. Epub 2022 Jan 25.
Silva M, Milanese G, Ledda RE, Nayak SM, Pastorino U, Sverzellati N. European lung cancer screening: valuable trial evidence for optimal practice implementation. Br J Radiol. 2022 May 1;95(1133):20200260. doi: 10.1259/bjr.20200260. Epub 2022 Jan 7.
Rundo L, Ledda RE, di Noia C, Sala E, Mauri G, Milanese G, Sverzellati N, Apolone G, Gilardi MC, Messa MC, Castiglioni I, Pastorino U. A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules. Diagnostics (Basel). 2021 Sep 3;11(9):1610. doi: 10.3390/diagnostics11091610.
Tringali G, Milanese G, Ledda RE, Pastorino U, Sverzellati N, Silva M. Lung Cancer Screening: Evidence, Risks, and Opportunities for Implementation. Rofo. 2021 Oct;193(10):1153-1161. doi: 10.1055/a-1382-8648. Epub 2021 Mar 26.
Silva M, Milanese G, Sestini S, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Marchiano A, Sverzellati N, Pastorino U. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval. Eur Radiol. 2021 Apr;31(4):1956-1968. doi: 10.1007/s00330-020-07275-w. Epub 2020 Sep 30.
Pastorino U, Sverzellati N, Sestini S, Silva M, Sabia F, Boeri M, Cantarutti A, Sozzi G, Corrao G, Marchiano A. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening. Eur J Cancer. 2019 Sep;118:142-148. doi: 10.1016/j.ejca.2019.06.009. Epub 2019 Jul 20.
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchiano A. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019 Oct 1;30(10):1672. doi: 10.1093/annonc/mdz169. No abstract available.
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchiano A. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117.
Gallus S, Lugo A, Suatoni P, Taverna F, Bertocchi E, Boffi R, Marchiano A, Morelli D, Pastorino U. Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants. Sci Rep. 2018 Aug 27;8(1):12908. doi: 10.1038/s41598-018-29867-9.
Silva M, Prokop M, Jacobs C, Capretti G, Sverzellati N, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Galeone C, Marchiano A, Pastorino U. Long-Term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment. J Thorac Oncol. 2018 Oct;13(10):1454-1463. doi: 10.1016/j.jtho.2018.06.013. Epub 2018 Jul 16.
Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357. Epub 2014 Jan 13.
Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012 May;21(3):308-15. doi: 10.1097/CEJ.0b013e328351e1b6.
National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
Becker N, Motsch E, Trotter A, Heussel CP, Dienemann H, Schnabel PA, Kauczor HU, Maldonado SG, Miller AB, Kaaks R, Delorme S. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer. 2020 Mar 15;146(6):1503-1513. doi: 10.1002/ijc.32486. Epub 2019 Jun 20.
Quaife SL, Ruparel M, Dickson JL, Beeken RJ, McEwen A, Baldwin DR, Bhowmik A, Navani N, Sennett K, Duffy SW, Wardle J, Waller J, Janes SM. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. Am J Respir Crit Care Med. 2020 Apr 15;201(8):965-975. doi: 10.1164/rccm.201905-0946OC.

Brien, T L R; Ade, P; Barry, P S; Castillo-Dominguez, E; Ferrusca, D; Gomez, V; Hargrave, P; Hornsby, A; Hughes, D; Mauskopf, P; Papageorgiou, A; Pascale, E; Rowe, S; Tapia, M; Tucker, C; Velazquez, M; Ventura, S; Doyle, S

2020 45th International Conference on Infrared, Millimeter, and Terahertz Waves (IRMMW-THz) Infrared, Millimeter, and Terahertz Waves (IRMMW-THz), 2020 45th International Conference on. :1-1 Nov, 2020

Ostapkowicz, Joanna; Widenhoeft, Alex C.; Brock, Fiona; Snoeck, Christophe; Cartwright, Caroline; Uden, Jeremy; Baittinger, Claudia; Gabriel, Mille; Gordon, Julie; Richardin, Pascale; Lavier, Catherine; Clauzel, Thibault; Friedrich, Ronny; Doppes, Doris; Berger, Martin E.; Alves, Marcony Lopes; Pouncett, John; Wood, Rachel; Schulting, Rick J.

JOURNAL OF ARCHAEOLOGICAL SCIENCE-REPORTS; APR 2026, 70 21p.

Shakespeare Bulletin. 37(3):461-465

Mennella, A.; Ade, P.; Almela, A.; Amico, G.; Arnaldi, L. H.; Aumont, J.; Banfi, S.; Battistelli, E. S.; Bélier, B.; Bergé, L.; Bernard, J. -Ph.; de Bernardis, P.; Bersanelli, M.; Bonaparte, J.; Bonilla, J. D.; Bunn, E.; Buzi, D.; Cacciotti, F.; Camilieri, D.; Cavaliere, F.; Chanial, P.; Chapron, C.; Colombo, L.; Columbro, F.; Coppolecchia, A.; Costanza, M. B.; D'Alessandro, G.; De Gasperis, G.; De Leo, M.; De Petris, M.; Del Castillo, N.; Dheilly, S.; Etchegoyen, A.; Ferazzoli, S.; Ferreyro, L. P.; Franceschet, C.; Lerena, M. M. Gamboa; Ganga, K.; García, B.; Redondo, M. E. García; Gayer, D.; Geria, J. M.; Gervasi, M.; Giard, M.; Gilles, V.; Berisso, M. Gómez; Gonzalez, M.; Gradziel, M.; Grandsire, L.; Hamilton, J. -Ch.; Hampel, M. R.; Isopi, G.; Kaplan, J.; Lamagna, L.; Lazarte, F.; Loucatos, S.; Maffei, B.; Mancilla, A.; Mandelli, S.; Manzan, E.; Marchitelli, E.; Marnieros, S.; Marty, W.; Masi, S.; May, A.; Maya, J.; McCulloch, M.; Mele, L.; Melo, D.; Mirón-Granese, N.; Montier, L.; Mousset, L.; Müller, N.; Nati, F.; O'Sullivan, C.; Paiella, A.; Pajot, F.; Paradiso, S.; Pascale, E.; Passerini, A.; Pelosi, A.; Perciballi, M.; Pezzotta, F.; Piacentini, F.; Piat, M.; Piccirillo, L.; Pisano, G.; Platino, M.; Polenta, G.; Prêle, D.; Rambaud, D.; Ramos, G.; Rasztocky, E.; Régnier, M.; Reyes, C.; Rodríguez, F.; Rodríguez, C. A.; Romero, G. E.; Salum, J. M.; Schillaci, A.; Scóccola, C.; Stankowiak, G.; Tartari, A.; Thermeau, J. -P.; Timbie, P.; Tomasi, M.; Torchinsky, S.; Tucker, G.; Tucker, C.; Vacher, L.; Voisin, F.; Wright, M.; Zannoni, M.; Zullo, A.

Blue, Russell S.; Wampler, Jeff; Wise, G. Bowden; Hoebel, Louis J.; Yamrom, Boris; Volpe, Christopher R.; Wilde, Bruce; Rondot, Pascale; Kelly, Ann E.; Gilman, Anne; Turner, Wesley; Linthicum, Steve; Ryon, George

CHI '02 Extended Abstracts on Human Factors in Computing Systems. :494-495

Yazbeck, Nadine; Zalzal, Rudy N.; El Oueichek, Fadi; Samaha, Jinane; Barhoumi, Abir; Karam, Pascale E.

International Journal of Pediatrics. August 29, 2025, Vol. 2025

Jreissati, Jean-Marc T.; Lawandos, Leonard; Jreissati, Julien T.; Karam, Pascale E.

Metabolites. July, 2025, Vol. 15 Issue 7

Nadine Yazbeck; Rima Hanna-Wakim; Dolly Noun; Pascale E. Karam

Clin Med Insights Pediatr

Yazbeck, Nadine; Barhoumi, Abir; Karam, Pascale E.

METABOLITES; JAN 8 2026, 16 1, p56 9p.

Slavonic and East European Review. 92(1):133-134